Tricor and Prostatic specific antigen increased - a phase IV clinical study of FDA data

Summary:

Prostatic specific antigen increased is reported as a side effect among people who take Tricor (fenofibrate), especially for people who are 60+ old, also take Xtandi, and have Prostate cancer.

The phase IV clinical study analyzes which people have Prostatic specific antigen increased when taking Tricor. It is created by eHealthMe based on reports of 21,730 people who have side effects when taking Tricor from the FDA, and is updated regularly.

What is Tricor?

Tricor has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 22,641 Tricor users. Check the latest studies of Tricor.

What is Prostatic specific antigen increased?

Prostatic specific antigen increased is found to be associated with 717 drugs and 692 conditions by eHealthMe. Check the latest studies of Prostatic specific antigen increased.

On Aug, 01, 2026

21,730 people reported to have side effects when taking Tricor.
Among them, 26 people (0.12%) have Prostatic specific antigen increased.

Could Tricor cause Prostatic specific antigen increased?

Among these 26 people:

What is the age of people who have Prostatic specific antigen increased when taking Tricor? *

What are other drugs people take besides Tricor? *

What are other side effects people have besides Prostatic specific antigen increased? *

Weakness: 6 people, 23.08%
Fatigue (feeling of tiredness): 6 people, 23.08%
Muscle Aches (muscle pain): 4 people, 15.38%
Urinary Tract Infection: 4 people, 15.38%
Nausea (feeling of having an urge to vomit): 4 people, 15.38%
Constipation: 4 people, 15.38%
Dehydration (dryness resulting from the removal of water): 3 people, 11.54%
Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 3 people, 11.54%
Prostatic Disorder: 3 people, 11.54%
Renal Cell Carcinoma (a kidney cancer): 2 people, 7.69%

What are the existing conditions these people have? *

Prostate Cancer: 6 people, 23.08%
Type 2 Diabetes: 3 people, 11.54%
Urination - Painful: 2 people, 7.69%
Renal Disorder (kidney disease): 2 people, 7.69%
Prostate Cancer Metastatic: 2 people, 7.69%
Lymphoma (cancer that begins in immune system cells): 2 people, 7.69%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 7.69%
Gout (uric acid crystals building up in the body): 1 person, 3.85%
Blood Testosterone Increased: 1 person, 3.85%
Cardiac Failure Congestive: 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Tricor and have Prostatic specific antigen increased?

- Check whether Prostatic specific antigen increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tricor:

Tricor (22,641 reports)

Browse all side effects of Tricor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Prostatic specific antigen increased:

Prostatic specific antigen increased (717 drugs)

Browse all the conditions that are associated with Prostatic specific antigen increased:

Prostatic specific antigen increased (692 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Tricor) and Tricor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.